ProQR Therapeutics N.V. (PRQR) Tops Q1 EPS by 1c

ProQR Therapeutics N.V. (NASDAQ: PRQR) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.45 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on ProQR Therapeutics N.V. (PRQR) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• FedEx (FDX) PT Lowered to $397 at Bernstein SocGen Group
• Paychex beats fourth quarter EPS estimates, stock slides